Stem Cells Market Outlook:
Stem Cells Market size was over USD 15.86 billion in 2024 and is poised to exceed USD 45.85 billion by 2034, witnessing over 11.2% CAGR during the forecast period i.e., between 2025-2034. In the year 2025, the industry size of stem cell treatment is evaluated at USD 17.37 billion.
The market growth is driven by growing prevalence of chronic diseases such as, cancer, sickle cell disease, lymphoproliferative disorders, tumors, and others. According to WHO, cancer accounted for nearly ten million deaths worldwide in 2020. A study conducted by the International Agency for Research on Cancer 2020 found that approximately 1 in 5 people develops cancer during their lifetime, and about 1 in 8 men and 1 in 11 women die from it. Early diagnosis allows for a more targeted cancer treatment, such as stem cell therapy, which can be more effective than traditional chemotherapy and radiation treatments. Stem cell involve using stem cells to stimulate the body's own immune system to attack cancer cells. The stem cells can also be used to replace damaged cells and restore function to organs that have been damaged by cancer.
In addition, growing demand for regenerative and personalized medicines, and rise in government funding for stem cell research will impel the market revenue. Stem cells can be used to create personalized medicines tailored to the individual needs of a patient.
